Appraisal Economics Inc. has completed the valuation of the economic rights contained in a private placement of common stock for a publicly traded biopharmaceutical company. The company develops therapies for the treatment of cancer and other serious diseases, focusing on cell cycle biology. In addition to its existing commercial products, the company has a pipeline of small molecule investigational drugs through Phase 3 trials. We valued the rights contained in the private placement derived from a lawsuit related to patent infringement, including the valuation of common stock warrants. We valued the warrants using the Black Scholes option pricing model and valued the patent infringement lawsuit using probability analysis and assessment of contingent claims.
Please click for more information about the valuation of patents, warrants, common stock, or litigation support.